Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine

Pharmacology Biochemistry and Behavior

Volumn 84, Issue 2, 2006, Pages 321-329

  Sindhu, Kizhakke M ^a   Banerjee, Rebecca ^a   Senthilkumar, Karuppagounder S ^a   Saravanan, Karuppagounder S ^a   Raju, B China ^b   Rao, J Madhusudan ^b   Mohanakumar, Kochupurackal P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

6 OHDA; animal model; Circling behavior; Complex I inhibitor; Contralateral and ipsilateral rotations; Dopamine receptor supersensitivity; Drug screening; MPP+; Parkinson's disease; Rotenone

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; AMPHETAMINE; APOMORPHINE; DOPAMINE; NEUROTOXIN; OXIDOPAMINE; ROTENONE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DRUG SENSITIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MEDIAL FOREBRAIN BUNDLE; NEUROCHEMISTRY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; STEREOTAXIS; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; MALE; MEDIAL FOREBRAIN BUNDLE; OXIDOPAMINE; RATS; ROTATION; ROTENONE; SUBSTANTIA NIGRA;

ANIMALIA; PARKINSONIA;

EID: 33746493307     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.05.017     Document Type: Article

References (48)

1. Agid Y., Javoy F., and Glowinski J. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. Nat New Biol 245 (1973) 150-151
2. Alam M., and Schmidt W.J. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136 (2002) 317-324
3. Alam M., and Schmidt W.J. l-DOPA reverses the hypokinetic behavior and rigidity in rotenone-treated rats. Behav Brain Res 153 (2004) 439-446
4. Alam M., Mayerhofer A., and Schmidt W.J. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by l-DOPA. Behav Brain Res 151 (2004) 117-184
5. Beckstead R.M., Wooten G.F., and Trugman J.M. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography. J Comp Neurol 268 (1988) 131-145
6. Besson M.J., Graybiel A.M., and Nastuk M.A. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions. Neuroscience 26 (1988) 101-119
7. Betarbet R., Sherer T.B., MacKenzie G., Osuna M.G., Pavanov V.A., and Greenamyre T.J. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3 (2000) 1301-1306
8. Castaneda E., Whishaw I.Q., and Robinson T.E. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 10 (1990) 1847-1854
9. Clavier R.M., Atmadja S., and Fibiger H.C. Nigrothalamic projections in the rat as demonstrated by orthograde and retrograde tracing techniques. Brain Res Bull 1 (1976) 379-384
10. Cohen G., Pasik P., Cohen B., Leist A., Mytilineou C., and Yahr M.D. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys. Eur J Pharmacol 106 (1984) 209-210
11. Deniau J.M., and Chevalier G. Disinhibition as a basic process in the expression of striatal functions: II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus. Brain Res 334 (1985) 227-233
12. Deniau J.M., and Chevalier G. The lamellar organization of the rat substantia nigra pars reticulata: distribution of projection neurons. Neuroscience 46 (1992) 361-377
13. Faull R.L., and Mehler W.R. The cells of origin of nigrotectal, nigrothalamic and nigrostriatal projections. Neuroscience 3 (1978) 989-992
14. Fleming S.M., Zhu C., Fernagut P.O., Mehta A., DiCarlo C.D., Seaman R.L., et al. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol 187 (2004) 418-429
15. Ghorayeb I., Fernagut P.O., Hervier L., Labattu B., Bioulac B., and Tison F. A 'Single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioral analysis. Neuroscience 115 (2002) 33-46
16. Hefti F., Melamed E., and Wurtman R.J. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res 195 (1980) 123-137
17. Heikkila R.E., Manzino L., Cabbat F.S., and Duvoisin R.C. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311 (1984) 467-469
18. Heikkila R.E., Nicklas W.J., Vyas I., and Duvoisin R.C. Dopaminergic, toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci Lett 62 (1985) 389-394
19. Hudson J.L., van Horne C.G., Stromberg I., Brock S., Clayton J., Masserano J., et al. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626 (1993) 167-174
20. Iwamoto E.T., Loh H.H., and Way E.L. Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions. Eur J Pharmacol 37 (1976) 339-356
21. Jasso-Lopez D., and Tapia R. Neurotoxic effect of intranigral injection of 1-methyl-4-phenylpyridinium on GABA-containing neurons and its relation to circling behavior. J Neurochem 64 (1995) 794-801
22. Jourdain S., Morissette M., Morin N., and Di Palo T. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. J Neuroendocrinol 17 (2005) 509-517
23. Kondo J., Kitamura Y., Inden M., and Taniguchi T. Hemiparkinsonian rat models: different sensitivity of dopaminergic neurotoxins. Int Congr Ser 1260 (2004) 281-285
24. Konitsiotis S., Kafetzopoulos E., Anastasopoulos D., and Blanchet P.J. Opposite rotation induced by dopamine agonists in rats with unilateral lesions of the globus pallidus or substantia nigra. Behav Brain Res 92 (1998) 77-83
25. Kopin I.J., and Markey S.P. MPTP toxicity: implication for research in Parkinson's disease. Ann Rev Neurosci 11 (1988) 81-86
26. +). J Toxicol Clin Exp 9 (1989) 21-25
27. + administration. Eur J Pharmacol 175 (1990) 57-61
28. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
29. Mayer R.A., Kindt M.V., and Heikkila R.E. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. J Neurochem 47 (1986) 1073-1079
30. Mitra N., Mohanakumar K.P., and Ganguly D.K. Resistance of golden Hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship with low levels of regional monoamine oxidase-B. J Neurochem 62 (1994) 1906-1912
31. Mizuno Y., Saitoh T., and Sone N. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion. Biochem Biophys Res Commun 143 (1987) 294-309
32. Muralikrishnan D., and Mohanakumar K.P. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice. FASEB J 12 (1998) 905-912
33. Nauta W.J.H., and Domesick V.B. Afferent and efferent relationships of the basal ganglia. In: Evered D., and O'Connor M. (Eds). Functions of the Basal Ganglia (Ciba Foundation Symposium 107) (1984), Pitman, London 3-29
34. Nicklas W.J., Vyas I., and Heikkila R.E. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36 (1985) 2503-2508
35. Palkovits M., and Brownstein M.J. Microdissection of brain areas by punch techniques. In: Cuello A.C. (Ed). Brain Microdissection techniques (1983), John Wiley & Sons, New York 1-36
36. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. (1998), Academic Press, San Diego
37. Pisa M. Regional specialization of motor functions in the rat striatum: implications for the treatment of parkinsonism. Prog Neuropsychopharmacol Biol Psychiatry 12 (1988) 217-224
38. Saravanan K.S., Sindhu K.M., and Mohanakumar K.P. Intranigral infusion of rotenone leads to oxidative stress and striatal dopaminergic toxicity in rats. Ann Neurosci 8 (2001) 30
39. Saravanan K.S., Sindhu K.M., and Mohanakumar K.P. Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease. Brain Res 1049 (2005) 147-155
40. Schwarting R.K., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50 (1996) 275-331
41. Schwarting R.K., Bonatz A.E., Carey R.J., and Huston J.P. Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections. Brain Res 554 (1991) 46-55
42. Silverman P.B., and Ho B.T. Persistent behavioural effect in apomorphine in 6-hydroxydopamine-lesioned rats. Nature 294 (1981) 475-477
43. Sindhu K.M., Saravanan K.S., and Mohanakumar K.P. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intra-nigral or median forebrain bundle infusion. Brain Res 1051 (2005) 25-34
44. + into the nigrostriatal dopamine pathway: I. Behavioral, neurochemical and histological characterization of the lesion. Neuroscience 27 (1988) 117-128
45. + into the nigrostriatal dopamine pathway: III. Reversal by embryonic nigral dopamine grafts. Neuroscience 37 (1990) 757-766
46. +. J Neural Transm 74 (1988) 75-86
47. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol Scand Suppl 367 (1971) 69-93
48. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res 24 (1970) 485-493